孕产妇补充甲基供体:对后代代谢障碍的潜在治疗方法
Yaolin Ren1, Yuan Zeng1, Yifan Wu1
1Key Laboratory of Endocrinology, Ministry of Health, Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
The Journal of nutritional biochemistry
|November 17, 2023
概括
母亲补充甲基供体,包括叶酸和胆,可以保护后代免受肥胖和糖尿病等代谢障碍. 这些干预措施可能会扭转跨世代的负面健康影响.
科学领域:
- 营养科学 营养科学
- 发育生物学 发展生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 糖尿病和肥胖的全球流行率上升是一个重大的社会挑战.
- 早期发育过程中的环境因素极大地影响后代的代谢健康.
- 甲基供体干预措施在缓解代谢障碍方面显示出前景.
研究的目的:
- 审查母亲甲基捐赠者在预防后代代谢障碍方面的作用.
- 总结临床和动物研究中关于甲基供体影响的证据.
- 讨论涉及的表观遗传和遗传机制.
主要方法:
- 临床研究的系统审查.
- 对实验动物模型的分析.
- 检查表观遗传修饰和基因表达变化.
主要成果:
- 孕产妇的甲基供体 (叶酸,贝他因,维生素B12,氨酸,胆) 对后代的新陈代谢有积极的影响.
- 证据支持甲基供体对代谢功能障碍的保护作用.
- 机制包括表观遗传调节和改变的代谢相关基因.
结论:
- 孕产妇补充甲基供体是对抗后代代谢障碍的潜在策略.
- 生命早期的干预可以扭转代谢问题,防止代际影响.
- 这些发现对公共卫生和预防医学具有临床意义.
相关概念视频
Animal Mitochondrial Genetics
7.6K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.6K
Genomic Imprinting and Inheritance
34.6K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
34.6K
Inborn Errors of Metabolism
165
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
165
Pathophysiology of Diabetes
950
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
950
Phase II Reactions: Methylation Reactions
199
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
199
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K


